
Name
MINE
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for MINE
Name
Alternate Names
CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone
Abbreviations
DAD
DHAD
DHAQ
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
301739
Primary Site
Histology
None
Remarks
Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione
Coding
This drug should be coded
Name
Alternate Names
Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar
Abbreviations
EPEG
VP-16
VP-16-213
Category
Chemotherapy
Subcategory
Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid
NSC Number
141540
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
D 7093
Mesna rescue
Mesnex
Mesnex uroprotection
Mesnum
Mistabron
Mitexan
Mucofluid
Sodium 2-mercaptoethanolsulfonate
UCB 3983
Uromitexan
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
113891
Primary Site
None
Histology
None
Remarks
A prophylactic detoxifying agent used to inhibit hemorrhagic cystitis caused by ifosfamide. FDA approved for bladder protection when using cyclophosphamide (prevents bladder toxicity).
Coding
This drug should NOT be coded
Name
Alternate Names
A-4942
Asta Z-4942
Cyfos#
Holoxan 1000
Ifex
Ifosfamid
Ifoxan
Iphosphamid
Iphosphamide
Iso-endoxan
Isofosfamide
Isophos-phamide
Isophosphamide
Mitoxana
MJF 9325
MJF-9325
Naxamide#
Z4942
Abbreviations
IFX
IPP
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
109724
Primary Site
Bladder
Cervical cancer
Ewing sarcoma
Head and Neck
Hodgkin lymphoma
Non-Hodgkin lymphoma
Testicular cancer
Histology
None
Remarks
Antineoplastic with alkylating activity. FDA approved.
Coding
This drug should be coded
